老年直肠癌患者术前中性粒细胞淋巴细胞比率与淋巴结转移及预后的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

陕西省教育厅专项科研计划项目(21JK0996)


Relationship between preoperative neutrophil-to-lymphocytea ratio and lymph node metastasis and prognosis in elderly patients with rectal cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探究老年直肠癌患者术前中性粒细胞淋巴细胞比率(NLR)与淋巴结转移及预后的关系。方法 回顾性收集2019年2月—2020年2月我院收治的行直肠癌根治切除术且术后病理证实为直肠癌的老年患者102例作为观察对象。收集所有患者临床资料;采集血样标本测定中性粒细胞、淋巴细胞计数,并计算NLR。以NLR临界值为3.96作为分组标准,将102例患者分为高NLR组(NLR>3.96,n=40)和低NLR组(NLR≤3.96,n=62)。比较不同水平NLR患者肿瘤解剖学位置、肿瘤直径和淋巴结转移情况等临床病理资料。并对所有患者进行2年随访,分析影响患者预后的相关因素。结果 高NLR组和低NLR组老年直肠癌患者解剖学部位、糖尿病史、高血压史、肿瘤直径和肿瘤体积等临床病理参数之间比较差异均无统计学意义(均P>0.05),高NLR组存在淋巴结转移、远处转移和TNM分期越晚的患者占比较低NLR组多,且淋巴结转移、远处转移和TNM分期均是影响NLR的相关因素(P<0.05)。单因素分析结果显示,肿瘤直径和体积越大、出现淋巴结转移、远处转移、TNM分期越晚和NLR水平越高的患者生存率越低(P<0.05)。多因素回归分析结果显示,存在淋巴结转移、TNM分期越晚和NLR高于3.96均是老年直肠癌患者预后的独立影响因素(P<0.05)。高NLR组患者中位生存期为22个月,低NLR组患者中位生存期随访结束未达到,高NLR组患者生存率明显低于低NLR组(P<0.05)。结论 老年直肠癌患者术前NLR与患者淋巴结转移及预后高度相关,NLR水平越高,出现淋巴结转移的概率越大,患者预后越差,提示NLR可作为预测和评估老年直肠癌患者预后的重要标志物

    Abstract:

    Objective To explore and analyze the relationship between preoperative neutrophil-to-lymphocyte ratio (NLR), lymph node metastasis and prognosis in elderly patients with rectal cancer. Methods 102 elderly patients who underwent radical resection of rectal cancer were postoperative pathologically confirmed as rectal cancer in the hospital from February 2019 to February 2020 were retrospectively collected as the research subjects. The clinical data of all patients were collected, the blood samples were collected and the neutrophil count and lymphocyte count were determined. And the NLR was calculated. With the NLR cutoff value of 3.96 as the grouping standard, 102 patients were divided into high NLR group (NLR>3.96, n=40) and low NLR group (NLR≤3.96, n=62). Clinicopathological data such as tumor anatomical location, tumor diameter and lymph node metastasis were compared among patients with different levels of NLR. All patients were followed up for 2 years, and the related factors affecting the prognosis of patients were analyzed.Results There were no statistical differences in clinicopathological parameters such as anatomical location, history of diabetes mellitus, history of hypertension, tumor diameter and tumor volume between high NLR group and low NLR group in elderly patients with rectal cancer (P>0.05). The proportions of patients with lymph node metastasis, distant metastasis and later TNM stage were more in high NLR group than those in low NLR group. The lymph node metastasis, distant metastasis and TNM staging were all related factors affecting NLR (P<0.05). Univariate analysis showed that survival rate was lower among patients with larger tumor diameter and tumor volume, lymph node metastasis, distant metastasis, later TNM stage and higher NLR level (P<0.05). Multivariate regression analysis showed that the presence of lymph node metastasis, later TNM stage and NLR higher than 3.96 were independent influencing factors for prognosis of elderly patients with rectal cancer (P<0.05). The median survival time of patients in high NLR group was 22 months, and the median survival time of patients in low NLR group was not reached at the end of follow-up. The survival rate of patients in high NLR group was significantly lower than that in low NLR group (P<0.05).Conclusion Preoperative NLR in elderly patients with rectal cancer is highly correlated with lymph node metastasis and prognosis. The higher the level of NLR, the greater the probability of lymph node metastasis and the worse the prognosis of patients, suggesting that NLR can be used as an important marker in predicting and evaluating the prognosis of elderly patients with rectal cancer

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-12-20
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司